Search Results

There are 9626 results for: content related to: A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

  1. You have full text access to this Open Access content
    Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors

    Cancer Science

    Volume 103, Issue 11, November 2012, Pages: 1946–1954, Kunihiko Minakata, Fumiyuki Takahashi, Takeshi Nara, Muneaki Hashimoto, Ken Tajima, Akiko Murakami, Fariz Nurwidya, Suzu Yae, Fumiaki Koizumi, Hiroyuki Moriyama, Kuniaki Seyama, Kazuto Nishio and Kazuhisa Takahashi

    Article first published online : 14 SEP 2012, DOI: 10.1111/j.1349-7006.2012.02408.x

  2. Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2763–2776, Brian J. Trummer, Vandana Iyer, Sathy V. Balu-Iyer, Robert O'Connor and Robert M. Straubinger

    Article first published online : 11 MAY 2012, DOI: 10.1002/jps.23180

  3. You have full text access to this Open Access content
    Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 51–69, Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell and Barbara Klughammer

    Article first published online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00991.x

  4. You have free access to this content
    Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung


    Volume 118, Issue 4, 15 February 2012, Pages: 1032–1039, Gilberto de Lima Lopes Jr., Joel E. Segel, Daniel S. W. Tan, Young K. Do, Tony Mok and Eric A. Finkelstein

    Article first published online : 26 JUL 2011, DOI: 10.1002/cncr.26372

  5. You have free access to this content
    Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response

    International Journal of Cancer

    Volume 120, Issue 7, 1 April 2007, Pages: 1579–1590, Jean-Gabriel Judde, Magali Rebucci, Nicolas Vogt, Patricia de Cremoux, Alain Livartowski, Alain Chapelier, Carine Tran-Perennou, Karine Boye, Rémy Defrance, Marie-France Poupon and Rui-Alberto Bras-Gonçalves

    Article first published online : 4 JAN 2007, DOI: 10.1002/ijc.22364

  6. You have free access to this content
    Establishment of a human non-small cell lung cancer cell line resistant to gefitinib

    International Journal of Cancer

    Volume 116, Issue 1, 10 August 2005, Pages: 36–44, Fumiaki Koizumi, Tatsu Shimoyama, Fumiko Taguchi, Nagahiro Saijo and Kazuto Nishio

    Article first published online : 10 MAR 2005, DOI: 10.1002/ijc.20985

  7. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway

    British Journal of Dermatology

    Volume 164, Issue 1, January 2011, Pages: 38–46, P-H. Lu, T-C. Kuo, K-C. Chang, C-H. Chang and C-Y. Chu

    Article first published online : 23 NOV 2010, DOI: 10.1111/j.1365-2133.2010.10038.x

  8. You have free access to this content
    Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu

    International Journal of Cancer

    Volume 122, Issue 8, 15 April 2008, Pages: 1722–1729, Marie P. Piechocki, Susan K. Dibbley, Fulvio Lonardo and George H. Yoo

    Article first published online : 12 DEC 2007, DOI: 10.1002/ijc.23231

  9. You have free access to this content
    Gefitinib–phenytoin interaction is not correlated with the 14C-erythromycin breath test in healthy male volunteers

    British Journal of Clinical Pharmacology

    Volume 68, Issue 2, August 2009, Pages: 226–237, Stephanie Chhun, Celine Verstuyft, 1 Nathalie Rizzo-Padoin, 2 Guy Simoneau, Laurent Becquemont, 1 Ilana Peretti, 2 Alan Swaisland, 3 Robert Wortelboer, 4 Jean Francois Bergmann and Stephane Mouly

    Article first published online : 5 MAY 2009, DOI: 10.1111/j.1365-2125.2009.03438.x

  10. You have full text access to this OnlineOpen article
    Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

    Thoracic Cancer

    Volume 6, Issue 5, September 2015, Pages: 636–642, Yu-Tao Liu, Xue-Zhi Hao, Jun-Ling Li, Xing-Sheng Hu, Yan Wang, Zi-Ping Wang, Hong-Yu Wang, Bin Wang, Xiao-Hong Han, Xiang-Ru Zhang and Yuan-Kai Shi

    Article first published online : 21 MAY 2015, DOI: 10.1111/1759-7714.12267

  11. An Apoferritin-based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib

    Advanced Healthcare Materials

    Anchala I. Kuruppu, Lei Zhang, Hilary Collins, Lyudmila Turyanska, Neil R. Thomas and Tracey D. Bradshaw

    Article first published online : 23 NOV 2015, DOI: 10.1002/adhm.201500389

  12. You have free access to this content
    Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib

    International Journal of Cancer

    Volume 123, Issue 12, 15 December 2008, Pages: 2939–2949, Tiziana Servidei, Anna Riccardi, Simona Mozzetti, Cristiano Ferlini and Riccardo Riccardi

    Article first published online : 19 SEP 2008, DOI: 10.1002/ijc.23902

  13. You have full text access to this Open Access content
    Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation

    Cancer Science

    Volume 99, Issue 8, August 2008, Pages: 1679–1684, Akira Inoue, Hong Xin, Takuji Suzuki, Masahiko Kanehira, Yoshio Kuroki, Tatsuro Fukuhara, Toshiaki Kikuchi, Makoto Maemondo, Toshihiro Nukiwa and Yasuo Saijo

    Article first published online : 14 AUG 2008, DOI: 10.1111/j.1349-7006.2008.00857.x

  14. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 34, Issue 11, November 2012, Pages: 1517–1523, Cristina P. Rodriguez, David J. Adelstein, Lisa A. Rybicki, Jerrold P. Saxton, Robert R. Lorenz, Benjamin G. Wood, Joseph Scharpf and Denise I. Ives

    Article first published online : 16 DEC 2011, DOI: 10.1002/hed.21971

  15. You have free access to this content
    Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest

    The Anatomical Record

    Volume 292, Issue 8, August 2009, Pages: 1122–1127, Xiaohua Zhou, Maqing Zheng, Fang Chen, Yunxia Zhu, Wei Yong, Haiyan Lin, Yujie Sun and Xiao Han

    Article first published online : 30 JUL 2009, DOI: 10.1002/ar.20938

  16. You have free access to this content
    Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells

    International Journal of Cancer

    Volume 118, Issue 1, 1 January 2006, Pages: 209–214, Maarten L. Janmaat, José A. Rodriguez, Mariëlle Gallegos-Ruiz, Frank A.E. Kruyt and Giuseppe Giaccone

    Article first published online : 7 JUL 2005, DOI: 10.1002/ijc.21290

  17. You have full text access to this Open Access content
    Radiosensitizing effects of gefitinib at different administration times in vitro

    Cancer Science

    Volume 100, Issue 8, August 2009, Pages: 1520–1525, Hong-Qing Zhuang, Jian Sun, Zhi-Yong Yuan, Jun Wang, Lu-Jun Zhao, Ping Wang, Xiu-Bao Ren and Chang-Li Wang

    Article first published online : 20 APR 2009, DOI: 10.1111/j.1349-7006.2009.01190.x

  18. Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia

    European Journal of Haematology

    Volume 81, Issue 5, November 2008, Pages: 344–353, Elin Lindhagen, Anna Eriksson, Malin Wickström, Katarina Danielsson, Birgitta Grundmark, Roger Henriksson, Peter Nygren, Anna Åleskog, Rolf Larsson and Martin Höglund

    Article first published online : 10 JUL 2008, DOI: 10.1111/j.1600-0609.2008.01120.x

  19. You have free access to this content
    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01)


    Volume 118, Issue 24, 15 December 2012, Pages: 6234–6242, Jong-Mu Sun, Ki Hyeong Lee, Sang-we Kim, Dae Ho Lee, Young Joo Min, Hwan Jung Yun, Hoon Kyo Kim, Hong Suk Song, Yeul Hong Kim, Bong-Seog Kim, In Gyu Hwang, Keehyun Lee, Sook Jung Jo, Jae Won Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn and for the Korean Cancer Study Group (KCSG)

    Article first published online : 6 JUN 2012, DOI: 10.1002/cncr.27630

  20. You have free access to this content
    The Critical Role of the Epidermal Growth Factor Receptor in Endochondral Ossification

    Journal of Bone and Mineral Research

    Volume 26, Issue 11, November 2011, Pages: 2622–2633, Xianrong Zhang, Valerie A Siclari, Shenghui Lan, Ji Zhu, Eiki Koyama, Holly L Dupuis, Motomi Enomoto-Iwamoto, Frank Beier and Ling Qin

    Article first published online : 20 OCT 2011, DOI: 10.1002/jbmr.502